September 29, 2023 at 9:58 am
BioStem Technologies Takes on Diabetic Foot Ulcers with Innovative Wound Care Product
BioStem Technologies (OTC: BSEM) has received Investigational Review Board (IRB) approval for a clinical studythat will investigate the utilization and effects of its VendajeⓇ wound… [Read More]